Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Emerald Health Therapeutics Inc EMHTF

Healthcare Drug Manufacturers - Specialty & Generic Cannabis
Emerald is committed to creating new consumer experiences with distinct recreational, medical and wellness-oriented cannabis products with an emphasis on innovation and production excellence.


OTCQB:EMHTF - Post by User

Emerald Health Therapeutics Inc > EMERALD HEALTH ONLY THE FACT 9000 CUSTOMERS SAME AS APHRIA
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(151)
•••
Comment by Positivelive1on Apr 15, 2020 2:55pm
83 Views
Post# 30912950

RE:EMERALD HEALTH ONLY THE FACT 9000 CUSTOMERS SAME AS APHRIA

RE:EMERALD HEALTH ONLY THE FACT 9000 CUSTOMERS SAME AS APHRIAIf you are comparing EMH to APH- wow, what a stretch!
EMH -.17 cents
APH - $5.35 and climbing!
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities